Driehaus Capital Management’s Applied Therapeutics APLT Stock Holding History

Driehaus Capital Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-517,107	Closed	-$4.63M	–	380
2021 Q4	$4.63M	Sell	517,107 -122,450	-19%	-$1.61M	0.05%	294
2021 Q3	$10.6M	Sell	639,557 -4,633	-0.7%	-$80K	0.13%	221
2021 Q2	$13.4M	Buy	644,190 +4,732	+0.7%	+$89.6K	0.18%	184
2021 Q1	$12M	Buy	639,458 +172,479	+37%	+$3.72M	0.18%	176
2020 Q4	$10.3M	Sell	466,979 -160,021	-26%	-$3.33M	0.17%	175
2020 Q3	$13M	Sell	627,000 -127,261	-17%	-$3.31M	0.27%	105
2020 Q2	$27.3M	Buy	754,261 +162,780	+28%	+$6.81M	0.66%	36
2020 Q1	$19.3M	Buy	591,481 +531,481	+886%	+$21.5M	0.65%	38
2019 Q4	$1.64M	Buy	+60,000	New	+$1.03M	0.04%	286

Other funds holding APLT

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Driehaus Capital Management's APLT Position: Q1 2022 in Review

Driehaus Capital Management sold out of Applied Therapeutics (APLT) in Q1 2022, closing a stake of 517,107 shares — an estimated $4.63M sold.

Driehaus Capital Management first reported a position in APLT in Q4 2019 and held it in 9 quarters. The position peaked at $27.3M in Q2 2020. 71 funds tracked by Wall St. Rank hold APLT as of Q1 2022.

Driehaus Capital Management reported no remaining Applied Therapeutics position as of Q1 2022 after selling out during the quarter.
Driehaus Capital Management sold 517,107 Applied Therapeutics shares in Q1 2022, an estimated $4.63M.
Driehaus Capital Management first reported a position in Applied Therapeutics in Q4 2019 and held it in 9 quarters.
Driehaus Capital Management's Applied Therapeutics position peaked at $27.3M in Q2 2020.
71 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2022.

Based on Driehaus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.